Rainer Rupprecht Selected Research

Anxiety Disorders (Anxiety Disorder)

10/2023	Neurosteroids and translocator protein 18 kDa (TSPO) in depression: implications for synaptic plasticity, cognition, and treatment options.
3/2022	Neuroinflammation and psychiatric disorders: Relevance of C1q, translocator protein (18 kDa) (TSPO), and neurosteroids.
2/2014	The role of allopregnanolone in depression and anxiety.
11/2012	Translocator protein (18 kDa) (TSPO) as a therapeutic target for anxiety and neurologic disorders.
1/2012	Recent developments in potential anxiolytic agents targeting GABAA/BzR complex or the translocator protein (18kDa) (TSPO).
1/2011	Neurosteroids as neuromodulators in the treatment of anxiety disorders.
3/2008	The complex roles of neurosteroids in depression and anxiety disorders.
1/2008	World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the pharmacological treatment of anxiety, obsessive-compulsive and post-traumatic stress disorders - first revision.
1/2008	Neuroactive steroids as endogenous modulators of anxiety.
7/2006	Neuroactive steroids as modulators of depression and anxiety.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rainer Rupprecht Research Topics

Disease

16	Anxiety Disorders (Anxiety Disorder) 10/2023 - 01/2002
16	Panic Disorder (Panic Attack) 10/2014 - 01/2002
15	Major Depressive Disorder (Major Depressive Disorders) 10/2023 - 06/2005
12	Neuroinflammatory Diseases 01/2024 - 01/2014
12	Mood Disorders (Mood Disorder) 10/2023 - 03/2002
12	Tinnitus 01/2019 - 01/2012
9	Sleep Deprivation 03/2016 - 05/2002
7	Depressive Disorder (Melancholia) 04/2024 - 04/2004
7	Neoplasms (Cancer) 10/2023 - 12/2005
7	Schizophrenia (Dementia Praecox) 05/2019 - 08/2004
6	Glioma (Gliomas) 02/2023 - 01/2012
5	Inflammation (Inflammations) 01/2023 - 01/2014
5	Mental Disorders (Mental Disorder) 03/2022 - 01/2010
4	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 11/2022
4	Bipolar Disorder (Manic Depressive Psychosis) 05/2019 - 07/2003
3	Disease Progression 01/2024 - 03/2003
3	Glioblastoma (Glioblastoma Multiforme) 11/2023 - 07/2018
3	Postpartum Depression (Post-Natal Depression) 10/2023 - 01/2022
3	Treatment-Resistant Depressive Disorder 01/2022 - 01/2006
3	Gliosis 02/2019 - 12/2010
2	Mitochondrial Diseases (Mitochondrial Disease) 03/2024 - 01/2024
2	Cognitive Dysfunction 10/2023 - 01/2022
2	Atrophy 07/2023 - 01/2022
2	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2022 - 01/2019
2	Infections 05/2019 - 01/2017
2	Multiple Sclerosis 10/2017 - 03/2010
2	Sleepiness 01/2017 - 03/2016
2	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2012 - 07/2009
2	Substance-Related Disorders (Drug Abuse) 01/2010 - 01/2008
1	Obesity 01/2024
1	Clinical Deterioration 01/2024
1	COVID-19 11/2023
1	Wounds and Injuries (Trauma) 10/2023
1	Dementia (Dementias) 10/2023
1	Progressive Multifocal Leukoencephalopathy 06/2022
1	Acute Pain 05/2022
1	Tauopathies 01/2021
1	Necrosis 01/2021
1	Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome) 01/2021
1	Corticobasal Degeneration 01/2021

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2003
20	NeurosteroidsIBA 10/2023 - 01/2002
19	Antidepressive Agents (Antidepressants)IBA 03/2024 - 03/2003
12	LigandsIBA 04/2024 - 07/2009
8	Biomarkers (Surrogate Marker)IBA 01/2024 - 12/2010
7	Anti-Anxiety Agents (Anxiolytics)IBA 01/2012 - 01/2003
7	TetragastrinIBA 01/2011 - 02/2003
6	GABA-A Receptors (GABA(A) Receptor)IBA 11/2012 - 01/2002
6	gamma-Aminobutyric Acid (GABA)IBA 07/2009 - 01/2002
5	Amyloid (Amyloid Fibrils)IBA 01/2024 - 11/2022
5	BenzodiazepinesIBA 10/2023 - 05/2005
5	Amino Acids FDA Link 02/2023 - 07/2003
5	Antipsychotic Agents (Antipsychotics)IBA 06/2014 - 11/2005
4	Pregnanolone (Allopregnanolone)IBA 10/2023 - 02/2014
3	etifoxineIBA 04/2024 - 01/2023
3	Serotonin (5 Hydroxytryptamine)IBA 03/2024 - 11/2005
3	N- benzyl- N- ethyl- 2- (7,8- dihydro- 7- methyl- 8- oxo- 2- phenyl- 9H- purin- 9- yl)acetamideIBA 10/2023 - 07/2009
3	zuranoloneIBA 10/2023 - 01/2022
3	brexanoloneIBA 10/2023 - 01/2022
3	CytokinesIBA 01/2021 - 05/2019
3	Quetiapine Fumarate (Seroquel)FDA Link 06/2014 - 01/2012
3	Mirtazapine (Rexer)FDA LinkGeneric 01/2009 - 03/2003
3	Sodium Lactate FDA LinkGeneric 01/2006 - 02/2003
2	Interleukin-6 (Interleukin 6)IBA 01/2020 - 05/2019
2	ChemokinesIBA 05/2019 - 01/2017
2	Retinaldehyde (Retinal)IBA 02/2019 - 01/2014
2	Hypnotics and Sedatives (Sedatives)IBA 01/2019 - 01/2012
2	Butyric Acid (Butanoic Acid)IBA 11/2009 - 04/2004
2	GTP-Binding Proteins (G-Protein)IBA 07/2002 - 03/2002
1	Psychotropic Drugs (Psychoactive Drugs)IBA 11/2023
1	Peptides (Polypeptides)IBA 10/2023
1	MethyltransferasesIBA 10/2023
1	DNA (Deoxyribonucleic Acid)IBA 10/2023
1	Temozolomide (Temodar)FDA LinkGeneric 10/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2023
1	Complement System Proteins (Complement)IBA 10/2023
1	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 10/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 06/2022
1	Glucose (Dextrose)FDA LinkGeneric 06/2022
1	Opioid Analgesics (Opioids)IBA 05/2022
1	Immunologic Factors (Immunomodulators)IBA 03/2022
1	Diazepam (Valium)FDA LinkGeneric 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	Serotonin AgentsIBA 01/2022
1	Interleukin-17 (Interleukin 17)IBA 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	Interleukin-16 (Interleukin 16)IBA 01/2021
1	InterleukinsIBA 01/2021
1	Interleukin-15 (Interleukin 15)IBA 01/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	Interleukin-7 (Interleukin 7)IBA 01/2021
1	CC ChemokinesIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2019
1	Interleukin-1beta (Interleukin 1 beta)IBA 05/2019

Therapy/Procedure

14	Transcranial Magnetic Stimulation 01/2018 - 05/2002
7	Therapeutics 05/2021 - 01/2007
5	Drug Therapy (Chemotherapy) 01/2017 - 01/2006
2	Transcranial Direct Current Stimulation 01/2019 - 12/2017
2	Combined Modality Therapy 07/2018 - 01/2018
1	Radiotherapy 10/2023